KRAS and cervical squamous intraepithelial neoplasia: CIN‐F tumors frequently harbor mutations in TP53, and demonstrate amplifications in cell‐cycle‐related genes and RTK‐related pathway components, such as KRAS. We recently described a novel therapeutic strategy for KRAS‐amplified tumors.40